Antagonizing A1, A3, or A2A receptors promotes the infiltration of inflammatory cells, such as monocytes and macrophages, in adenosine-mediated vasculitis and plays critical roles in TME (Signa et al., 2022). Here, IGKV2D-29 is linked to vasculitis.